Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DHHCNASDAQ:HCMANASDAQ:PBAXNYSE:PRPB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHHCDiamondHead$3.01-21.4%$2.63$9.78▼$28.50$129.82M0.01350,931 shs1.17 million shsHCMAHCM Acquisition$10.55+4.7%$10.09$3.60▼$16.28$149.20M-0.2768,548 shs49,762 shsPBAXPhoenix Biotech Acquisition$5.85$5.83$4.12▼$12.80$36.56M0.0516,686 shs6,468 shsPRPBCC Neuberger Principal Holdings II$1.66-5.1%$1.81$7.86▼$10.12$137.45M0.03487,352 shs4.33 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHHCDiamondHead0.00%-9.06%-0.33%+5.61%-76.26%HCMAHCM Acquisition+4.66%+8.76%+12.00%+5.50%+6.14%PBAXPhoenix Biotech Acquisition0.00%0.00%0.00%0.00%0.00%PRPBCC Neuberger Principal Holdings II0.00%-10.27%-6.74%-7.26%-49.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDHHCDiamondHeadN/AN/AN/AN/AN/AN/AN/AN/AHCMAHCM AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APBAXPhoenix Biotech AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APRPBCC Neuberger Principal Holdings IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHHCDiamondHead 0.00N/AN/AN/AHCMAHCM Acquisition 0.00N/AN/AN/APBAXPhoenix Biotech Acquisition 0.00N/AN/AN/APRPBCC Neuberger Principal Holdings II 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHHCDiamondHeadN/AN/A$0.04 per share80.54($0.48) per shareN/AHCMAHCM AcquisitionN/AN/AN/AN/AN/AN/APBAXPhoenix Biotech AcquisitionN/AN/AN/AN/AN/AN/APRPBCC Neuberger Principal Holdings IIN/AN/AN/AN/A($1.42) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHHCDiamondHead$2.71MN/A0.00∞N/AN/A-68.55%2.04%N/AHCMAHCM AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/APBAXPhoenix Biotech AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/APRPBCC Neuberger Principal Holdings II-$2.70MN/A0.00∞N/AN/AN/A-1.58%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDHHCDiamondHeadN/AN/AN/AN/AN/AHCMAHCM AcquisitionN/AN/AN/AN/AN/APBAXPhoenix Biotech AcquisitionN/AN/AN/AN/AN/APRPBCC Neuberger Principal Holdings IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHHCDiamondHeadN/A0.010.06HCMAHCM AcquisitionN/AN/AN/APBAXPhoenix Biotech AcquisitionN/AN/AN/APRPBCC Neuberger Principal Holdings IIN/A0.680.68Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHHCDiamondHead74.00%HCMAHCM Acquisition11.79%PBAXPhoenix Biotech Acquisition16.74%PRPBCC Neuberger Principal Holdings IIN/AInsider OwnershipCompanyInsider OwnershipDHHCDiamondHead20.00%HCMAHCM Acquisition71.20%PBAXPhoenix Biotech Acquisition84.80%PRPBCC Neuberger Principal Holdings II0.11%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHHCDiamondHead243.13 millionN/ANot OptionableHCMAHCM AcquisitionN/A14.14 million4.07 millionNot OptionablePBAXPhoenix Biotech AcquisitionN/A6.25 million949,000Not OptionablePRPBCC Neuberger Principal Holdings II482.80 million82.71 millionNot OptionablePBAX, HCMA, PRPB, and DHHC HeadlinesRecent News About These CompaniesCC Neuberger Principal Holdings II (NYSE:PRPB) Shares Up 0.5% - Here's WhyJune 25, 2025 | marketbeat.comCC Neuberger Principal Holdings II (NYSE:PRPB) Stock Price Down 1.7% - Should You Sell?June 3, 2025 | marketbeat.comWhat is principal component analysis?November 3, 2024 | nature.comNPrincipal SmallCap Value II R1October 19, 2024 | morningstar.comMPrincipal SmallCap Value II R6September 18, 2024 | morningstar.comMThe Best CC Creams, According to Makeup ArtistsAugust 28, 2024 | nymag.comNCreative commons licensesAugust 3, 2024 | cambridge.orgCNeuberger Berman Real Estate R6July 31, 2024 | morningstar.comMCengage Learning Holdings II IncApril 19, 2024 | morningstar.comMChinh Chu's Net WorthMarch 31, 2024 | benzinga.comCC Neuberger Principal Holdings III WtSeptember 26, 2023 | barrons.comNeuberger Berman Intermediate Municipal Fund dividend declines by 24.9% to $0.0377February 18, 2023 | seekingalpha.comCC Neuberger Principal Stock (NYSE:PRPC), Short Interest ReportSeptember 26, 2022 | benzinga.comPRPB_u Historical DataAugust 18, 2022 | investing.comGetty Images, Inc.: Getty Images and CC Neuberger Principal Holdings II Complete Business CombinationJuly 25, 2022 | finanznachrichten.deCC Neuberger Principal Holdings II - Units (1 Ord Share Class A & 1/4 War)May 21, 2022 | fxempire.comFGetty Images to Participate at the J.P. Morgan Global Technology, Media and Communications ConferenceMay 17, 2022 | finance.yahoo.comGetty Images to Host Virtual Analyst Day on March 17, 2022March 9, 2022 | finance.yahoo.comGetty Images to Participate at JMP Securities Technology ConferenceFebruary 28, 2022 | finance.yahoo.comIs CC Neuberger Principal Holdings II (NYSE: PRPB) Worth Much? What Should Investors Do?January 7, 2022 | marketingsentinel.comMCC Neuberger Principal Holdings II Sees Unusually High Options Volume (NYSE:PRPB)December 30, 2021 | americanbankingnews.comMedia Sentiment Over TimePBAX, HCMA, PRPB, and DHHC Company DescriptionsDiamondHead NASDAQ:DHHC$3.01 -0.82 (-21.41%) As of 06/27/2025DiamondHead Holdings Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.HCM Acquisition NASDAQ:HCMA$10.55 +0.47 (+4.66%) As of 06/30/2025HCM Acquisition Corp does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. HCM Acquisition Corp was incorporated in 2021 and is based in Stamford, Connecticut.Phoenix Biotech Acquisition NASDAQ:PBAXPhoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.CC Neuberger Principal Holdings II NYSE:PRPB$1.66 -0.09 (-5.14%) As of 06/27/2025CC Neuberger Principal Holdings II does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. CC Neuberger Principal Holdings II was incorporated in 2020 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
